. J. Pr, Le Heuzey, pour la Société Française de cardiologie, web site, 2011.

S. E. Wolowacz, The cost of illness of atrial fibrillation: a systematic review of the recent literature, Europace, vol.13, issue.10, pp.1375-1385, 2011.
DOI : 10.1093/europace/eur194

D. Le-cours-du-pr and . Ribuot-c, Physiologie cardio-vasculaire

B. Aldhoon, V. Melenovský, P. Peichl, and J. Kautzner, New insights into mechanisms of atrial fibrillation, Physiol Res, vol.59, pp.1-12, 2010.

H. Calkins, J. Brugada, and D. Packer, ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation developed in partnership with the European Heart Rhythm Association (EHRA) and the European Cardiac Arrhythmia Society (ECAS); in collaboration with the American College of Cardiology (ACC), AHA), and the Society of Thoracic Surgeons (STS). Endorsed and approved by the governing bodies of the American College of Cardiology, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, and the Heart Rhythm Society, pp.335-379, 2007.

G. Moe and J. Abildskov, Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge, American Heart Journal, vol.58, issue.1, pp.59-70, 1959.
DOI : 10.1016/0002-8703(59)90274-1

F. Cosio, E. Aliot, and G. Botto, Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode, Europace, vol.10, issue.1, pp.21-27, 2008.
DOI : 10.1093/europace/eum276

M. Allessie, J. Ausma, and U. Schotten, Electrical, contractile and structural remodeling during atrial fibrillation, Cardiovascular Research, vol.54, issue.2, pp.230-246, 2002.
DOI : 10.1016/S0008-6363(02)00258-4

A. Camm, P. Kirchhof, and G. Lip, Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur Heart J, vol.31, pp.2369-2429, 2010.

. Le-sarcomère, Wikipédia web site URL : http://fr.wikipedia.org/wiki al. Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or Flutter, Sarcom%C3%A8re N Engl J Med, vol.18, issue.357, pp.987-999, 2007.

D. , L. Heuzey, and J. Y. , A Short-term, Randomized, Double-Blind, Parallel-group Study to Evaluate the Efficacy and Safety of Dronedarone versus Amiodarone in Patients with Persistent Atrial Fibrillation: The DIONYSOS Study, J Cardiovasc Electrophysiol, vol.21, issue.6, pp.606-607, 2010.

D. Touboul and P. , Dronedarone for prevention of atrial fibrillation: A dose-ranging study, European Heart Journal, vol.24, issue.16, pp.1481-1487, 2003.
DOI : 10.1016/S0195-668X(03)00321-X

E. Davy and J. M. , Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) study, American Heart Journal, vol.156, issue.3, pp.527-528, 2008.
DOI : 10.1016/j.ahj.2008.06.010

A. Hohnloser and H. S. , Effect of Dronedarone on Cardiovascular Events in Atrial Fibrillation, New England Journal of Medicine, vol.360, issue.7, pp.668-678, 2009.
DOI : 10.1056/NEJMoa0803778

A. Kober and L. , Increased Mortality after Dronedarone Therapy for Severe Heart Failure, New England Journal of Medicine, vol.358, issue.25, pp.2678-2687, 2008.
DOI : 10.1056/NEJMoa0800456

E. and M. Rcp, URL: http://www.ema.europa.eu/docs/document_library human/001043/WC500044534.pdf 25 : Food and Drug Administration, web site. URL : http://www.fda.gov/Safety, 2011.

S. Connolly, A. Camm, and J. Halperin, Dronedarone in High-Risk Permanent Atrial Fibrillation, New England Journal of Medicine, vol.365, issue.24, pp.10-1056, 2011.
DOI : 10.1056/NEJMoa1109867

F. and F. Drug, Safety Communication: Review update of Multaq (dronedarone) and increased risk of death and serious cardiovascular adverse events, web site : http://www.fda.gov/Drugs/DrugSafety, 2011.

N. Freemantle, C. Lafuente, S. Mitchell, L. Eckert, and M. Reynolds, Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation, Europace, vol.13, issue.3, pp.10-1093, 2011.
DOI : 10.1093/europace/euq450